Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.

@article{VadhanRaj2009ManagementOC,
  title={Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.},
  author={Saroj Vadhan-Raj},
  journal={Seminars in hematology},
  year={2009},
  volume={46 1 Suppl 2},
  pages={S26-32}
}
Myelosuppression, one of the most common toxicities of chemotherapy, results in varying degree of cytopenias. While neutropenia and anemia have been reduced with the currently approved hematopoietic growth factors, thrombocytopenia remains a significant clinical problem with an unmet medical need. Although platelet transfusions can provide a temporary solution, they do not address the underlying cause of thrombocytopenia. Management of chemotherapy-associated thrombocytopenia often involves… CONTINUE READING